Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -38.52% is 165% below its 5-year average of -14.54%, near the low end of its 5-year range (-38.52%–-6.62%).
119.67% below its 12-month average of -17.54%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -15.31%.
RETURN ON ASSETS (ROA)
-38.52%
RETURN ON ASSETS (ROA) AVG TTM
-17.54%
RETURN ON ASSETS (ROA) AVG 3Y
-16.16%
RETURN ON ASSETS (ROA) AVG 5Y
-14.54%
RETURN ON ASSETS (ROA) AVG 10Y
-42.36%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-119.67%
CURRENT VS 3Y AVG
-138.29%
CURRENT VS 5Y AVG
-164.86%
CURRENT VS 10Y AVG
+9.06%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-19.48%
vs the sector median at left
Quanterix Corporation
Market Cap
$162.28M
Return on Assets (ROA)
-38.52%
TTM Avg
-17.54%
3Y Avg
-16.16%
5Y Avg
-14.54%
Market Cap
$162.23M
Return on Assets (ROA)
-68.50%
TTM Avg
-29.78%
3Y Avg
-39.51%
5Y Avg
-30.76%
Market Cap
$160.65M
Return on Assets (ROA)
-414.72%
TTM Avg
-147.82%
3Y Avg
-101.66%
5Y Avg
-78.00%
Market Cap
$165.27M
Return on Assets (ROA)
-34.75%
TTM Avg
-23.73%
3Y Avg
-25.63%
5Y Avg
-26.84%
Market Cap
$165.88M
Return on Assets (ROA)
2.80%
TTM Avg
-4.42%
3Y Avg
-6.73%
5Y Avg
-5.05%
Market Cap
$159.44M
Return on Assets (ROA)
-50.88%
TTM Avg
-55.59%
3Y Avg
-49.48%
5Y Avg
-39.11%
Market Cap
$159.22M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
Market Cap
$166.54M
Return on Assets (ROA)
-534.43%
TTM Avg
-94.69%
3Y Avg
-82.47%
5Y Avg
-71.30%
Market Cap
$156.63M
Return on Assets (ROA)
-8.61%
TTM Avg
-9.87%
3Y Avg
-17.96%
5Y Avg
-12.40%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quanterix Corporation (QTRX) | $162.28M | -38.52% | -17.54% | -16.16% | -14.54% |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | -68.50% | -29.78% | -39.51% | -30.76% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.65M | -414.72% | -147.82% | -101.66% | -78.00% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -34.75% | -23.73% | -25.63% | -26.84% |
| OptimizeRx Corp. (OPRX)vs › | $165.88M | 2.80% | -4.42% | -6.73% | -5.05% |
| PepGen Inc. (PEPG)vs › | $159.44M | -50.88% | -55.59% | -49.48% | -39.11% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -35.50% | -18.07% | -62.20% | -134.72% |
| Cue Biopharma, Inc. (CUE)vs › | $166.54M | -534.43% | -94.69% | -82.47% | -71.30% |
| Inogen, Inc. (INGN)vs › | $156.63M | -8.61% | -9.87% | -17.96% | -12.40% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $154.34M | N/A | -34.95% | -49.76% | -43.08% |
ROA
-38.5%
ROE
-51.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -25.59% |
| 2024-12-31 | -9.48% |
| 2023-12-31 | -6.62% |
| 2022-12-31 | -22.97% |
| 2021-12-31 | -10.97% |
| 2020-12-31 | -11.63% |
| 2019-12-31 | -24.00% |
| 2018-12-31 | -45.91% |
| 2017-12-31 | -29.44% |
| 2016-12-31 | -62.43% |
| 2015-12-31 | -216.88% |
